CV
AMGN icon

Counterweight Ventures’s Amgen AMGN Stock Holding History

Counterweight Ventures’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.76M Sell
7,631
-264
-3% -$90.4K 1.38% 28
2026
Q1 		$2.78M Sell
7,895
-240
-3% -$85.6K 1.56% 26
2025
Q4 		$2.66M Sell
8,135
-31
-0.4% -$9.83K 1.49% 25
2025
Q3 		$2.3M Buy
8,166
+338
+4% +$98K 1.35% 26
2025
Q2 		$2.19M Buy
7,828
+94
+1% +$26.6K 1.43% 26
2025
Q1 		$2.41M Buy
7,734
+228
+3% +$67.3K 1.73% 24
2024
Q4 		$1.96M Buy
7,506
+97
+1% +$28.8K 1.38% 29
2024
Q3 		$2.39M Buy
7,409
+79
+1% +$25.8K 1.69% 25
2024
Q2 		$2.29M Buy
7,330
+205
+3% +$60.2K 1.73% 26
2024
Q1 		$2.03M Sell
7,125
-299
-4% -$87.5K 1.63% 29
2023
Q4 		$2.14M Buy
+7,424
New +$2.02M 1.94% 24

Other funds holding AMGN

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Counterweight Ventures's AMGN Position: Q2 2026 in Review

Counterweight Ventures reduced its Amgen (AMGN) stake by 3.3% in Q2 2026, selling an estimated $90.4K and leaving 7,631 shares worth $2.76M. The position accounts for 1.38% of the portfolio, ranked #28.

Counterweight Ventures first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.78M in Q1 2026. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Counterweight Ventures held 7,631 shares of Amgen worth $2.76M as of Q2 2026.
  • Counterweight Ventures sold 264 Amgen shares in Q2 2026, an estimated $90.4K.
  • Amgen made up 1.38% of Counterweight Ventures's portfolio in Q2 2026, its #28 holding.
  • Counterweight Ventures first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • Counterweight Ventures's Amgen position peaked at $2.78M in Q1 2026.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Counterweight Ventures's 13F filing for Q2 2026, filed 23 Jul 2026.